Atropine Sulfate Injection, Solution
NDC Package 71872-7002-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Atropine Sulfate injection is a medication used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). This formulation utilizes a injection, solution delivery system. Marketed by Medical Purchasing Solutions, Llc, this product is identified by NDC 71872-7002 and is authorized under FDA application NDA021146.

Identification & Billing

NDC Package Code
71872-7002-1
Package Description
10 CARTON in 1 BAG / 1 SYRINGE, PLASTIC in 1 CARTON / 10 mL in 1 SYRINGE, PLASTIC
Product Code
11-Digit Billing Format
71872700201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Atropine Sulfate
Non-Proprietary Name
Atropine Sulfate
Substance Name
Atropine Sulfate
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Endotracheal - Administration directly into the trachea.
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
Usage Information
This medication is used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.

Regulatory & Marketing

Labeler Name
Medical Purchasing Solutions, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA021146
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-19-2006
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71872-7002-1 identifies a specific commercial package of 10 carton in 1 bag / 1 syringe, plastic in 1 carton / 10 ml in 1 syringe, plastic of Atropine Sulfate, a human prescription drug labeled by Medical Purchasing Solutions, Llc. This injection, solution is formulated for endotracheal; intramuscular; intravenous; subcutaneous use and contains atropine sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medical Purchasing Solutions, Llc on January 19, 2006. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.

How is this Medical Purchasing Solutions, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71872700201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71872-7002-1
11-Digit CMS (5-4-2)
71872-7002-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.